This review highlights the role of systemic inflammation following acute myocardial infarction in driving adverse left ventricular remodeling and predicting poor clinical outcomes.
No takes yet. Share an insight, caveat, or question.
May guide post-AMI risk stratification via inflammation markers; leaves open whether targeted therapy improves outcomes.
Lü et al. (2015) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: